accountmost common form of lung tumours, that had started spreading. Bristol-Myers Squibb (BMY.N: Quote, Profile, Research) and Eli Lilly & Co (LLY.N: Quote, Profile, Research) hold the rights to Erbitux in the United States and Canada and they pursue separate...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 3-EU panel blocks Merck KGaA's Erbitux in lung cancer
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account